Physician profile
John E Scallions
NPI 1487951042
$29,976.58
in general payments reported to CMS, 2019-2025
18 companies · $688 in 2025
The $688 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $577 · 2022: $16K · 2023: $13K · 2024: $478 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $12K · Food and Beverage: $1,826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $11,916.67 |
| Food and Beverage | $1,826.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $27,506.91 | 2022-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $1,660.76 | 2021-2025 | Eluvia, Ranger, Jetstream Sc |
| Janssen Pharmaceuticals, INC | $128.83 | 2021-2022 | |
| Terumo Medical Corporation | $93.48 | 2024-2025 | Glidewire, Angio-Seal |
| Tactile Systems Technology INC | $85.38 | 2022-2025 | Flexitouch Plus, Nimbl |
| Medtronic, INC. | $70.78 | 2022-2023 | Venaseal |
| Reprise Biomedical, INC. | $69.85 | 2021-2025 | Miro 3d |
| Triad Life Sciences INC. | $58.25 | 2021 | |
| Advanced Oxygen Therapy INC. | $56.94 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Bayer Healthcare Pharmaceuticals INC. | $42.33 | 2023 | |
| Biotissue Holdings INC. | $42.15 | 2025 | |
| Abbvie INC. | $41.92 | 2021-2022 | |
| Radius Health, INC. | $24.43 | 2025 | Tymlos |
| Vertex Pharmaceuticals Incorporated | $21.32 | 2025 | |
| Si-Bone, INC. | $19.95 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $19.02 | 2021 | |
| Novo Nordisk INC | $18.25 | 2023 | |
| Novartis Pharmaceuticals Corporation | $16.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Scallions listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.